OC
NUVA

Oppenheimer & Co’s NuVasive, Inc. NUVA Stock Holding History

Oppenheimer & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,469
Closed -$1.95M – 1388
2015
Q3 		$1.95M Sell
40,469
-22,742
-36% -$1.18M 0.06% 370
2015
Q2 		$3M Buy
63,211
+53,115
+526% +$2.48M 0.08% 282
2015
Q1 		$464K Hold
10,096
– – 0.01% 899
2014
Q4 		$476K Buy
10,096
+600
+6% +$25K 0.01% 844
2014
Q3 		$331K Sell
9,496
-1,242
-12% -$44.2K 0.01% 1031
2014
Q2 		$382K Buy
+10,738
New +$368K 0.01% 951

Other funds holding NUVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oppenheimer & Co's NUVA Position: Q4 2015 in Review

Oppenheimer & Co sold out of NuVasive, Inc. (NUVA) in Q4 2015, closing a stake of 40,469 shares — an estimated $1.95M sold.

Oppenheimer & Co first reported a position in NUVA in Q2 2014 and held it in 6 quarters. The position peaked at $3M in Q2 2015. 233 funds tracked by Wall St. Rank hold NUVA as of Q4 2015.

  • Oppenheimer & Co reported no remaining NuVasive, Inc. position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 40,469 NuVasive, Inc. shares in Q4 2015, an estimated $1.95M.
  • Oppenheimer & Co first reported a position in NuVasive, Inc. in Q2 2014 and held it in 6 quarters.
  • Oppenheimer & Co's NuVasive, Inc. position peaked at $3M in Q2 2015.
  • 233 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.